Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 481

1.

Correction: Estrogen Signalling and the Metabolic Syndrome: Targeting the Hepatic Estrogen Receptor Alpha Action.

Matic M, Bryzgalova G, Gao H, Antonson P, Humire P, Omoto Y, Portwood N, Pramfalk C, Efendic S, Berggren PO, Gustafsson JÅ, Dahlman-Wright K.

PLoS One. 2019 Jun 19;14(6):e0217526. doi: 10.1371/journal.pone.0217526. eCollection 2019.

2.

Analyses of IGFBP2 DNA methylation and mRNA expression in visceral and subcutaneous adipose tissues of obese subjects.

Zhang X, Gu HF, Frystyk J, Efendic S, Brismar K, Thorell A.

Growth Horm IGF Res. 2019 Apr;45:31-36. doi: 10.1016/j.ghir.2019.03.002. Epub 2019 Mar 20.

PMID:
30921666
3.

17β-Estradiol suppresses visceral adipogenesis and activates brown adipose tissue-specific gene expression.

Al-Qahtani SM, Bryzgalova G, Valladolid-Acebes I, Korach-André M, Dahlman-Wright K, Efendić S, Berggren PO, Portwood N.

Horm Mol Biol Clin Investig. 2017 Jan 1;29(1):13-26. doi: 10.1515/hmbci-2016-0031.

PMID:
27831918
4.

Reduced incidence of Parkinson's disease after dipeptidyl peptidase-4 inhibitors-A nationwide case-control study.

Svenningsson P, Wirdefeldt K, Yin L, Fang F, Markaki I, Efendic S, Ludvigsson JF.

Mov Disord. 2016 Sep;31(9):1422-3. doi: 10.1002/mds.26734. Epub 2016 Jul 19. No abstract available.

PMID:
27431803
5.

ARA290 Improves Insulin Release and Glucose Tolerance in Type 2 Diabetic Goto-Kakizaki Rats.

Muller C, Yassin K, Li LS, Palmblad M, Efendic S, Berggren PO, Cerami A, Brines M, Östenson CG.

Mol Med. 2016 May;21(1):969-978. doi: 10.2119/molmed.2015.00267. Epub 2015 Dec 29.

6.

Genetic association of adrenergic receptor alpha 2A with obesity and type 2 diabetes.

Långberg EC, Seed Ahmed M, Efendic S, Gu HF, Östenson CG.

Obesity (Silver Spring). 2013 Aug;21(8):1720-5. doi: 10.1002/oby.20162. Epub 2013 Jun 11.

7.

Estrogen signalling and the metabolic syndrome: targeting the hepatic estrogen receptor alpha action.

Matic M, Bryzgalova G, Gao H, Antonson P, Humire P, Omoto Y, Portwood N, Pramfalk C, Efendic S, Berggren PO, Gustafsson JÅ, Dahlman-Wright K.

PLoS One. 2013;8(2):e57458. doi: 10.1371/journal.pone.0057458. Epub 2013 Feb 25. Erratum in: PLoS One. 2019 Jun 19;14(6):e0217526.

8.

Amelioration of hypoglycemia via somatostatin receptor type 2 antagonism in recurrently hypoglycemic diabetic rats.

Yue JT, Riddell MC, Burdett E, Coy DH, Efendic S, Vranic M.

Diabetes. 2013 Jul;62(7):2215-22. doi: 10.2337/db12-1523. Epub 2013 Feb 22.

9.

Sitagliptin improves beta-cell function in patients with acute coronary syndromes and newly diagnosed glucose abnormalities--the BEGAMI study.

Hage C, Brismar K, Efendic S, Lundman P, Rydén L, Mellbin L.

J Intern Med. 2013 Apr;273(4):410-21. doi: 10.1111/joim.12032. Epub 2013 Feb 14.

10.

High consumption of smokeless tobacco ("snus") predicts increased risk of type 2 diabetes in a 10-year prospective study of middle-aged Swedish men.

Östenson CG, Hilding A, Grill V, Efendic S.

Scand J Public Health. 2012 Dec;40(8):730-7. doi: 10.1177/1403494812459814. Epub 2012 Oct 31.

PMID:
23117209
11.

Increased expression of adenylyl cyclase 3 in pancreatic islets and central nervous system of diabetic Goto-Kakizaki rats: a possible regulatory role in glucose homeostasis.

Seed Ahmed M, Kovoor A, Nordman S, Abu Seman N, Gu T, Efendic S, Brismar K, Östenson CG, Gu HF.

Islets. 2012 Sep-Oct;4(5):343-8. doi: 10.4161/isl.22283. Epub 2012 Sep 1.

12.

Low serum 25-hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance.

Deleskog A, Hilding A, Brismar K, Hamsten A, Efendic S, Östenson CG.

Diabetologia. 2012 Jun;55(6):1668-78. doi: 10.1007/s00125-012-2529-x. Epub 2012 Mar 17.

PMID:
22426800
13.

Somatostatin receptor type 2 antagonism improves glucagon and corticosterone counterregulatory responses to hypoglycemia in streptozotocin-induced diabetic rats.

Yue JT, Burdett E, Coy DH, Giacca A, Efendic S, Vranic M.

Diabetes. 2012 Jan;61(1):197-207. doi: 10.2337/db11-0690. Epub 2011 Nov 21.

14.

Genetic and functional effects of membrane metalloendopeptidase on diabetic nephropathy development.

Zhang D, Gu T, Forsberg E, Efendic S, Brismar K, Gu HF.

Am J Nephrol. 2011;34(5):483-90. doi: 10.1159/000333006. Epub 2011 Oct 22.

PMID:
22024547
15.

Effects of MCF2L2, ADIPOQ and SOX2 genetic polymorphisms on the development of nephropathy in type 1 Diabetes Mellitus.

Zhang D, Efendic S, Brismar K, Gu HF.

BMC Med Genet. 2010 Jul 28;11:116. doi: 10.1186/1471-2350-11-116.

16.

Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis.

Edholm T, Degerblad M, Grybäck P, Hilsted L, Holst JJ, Jacobsson H, Efendic S, Schmidt PT, Hellström PM.

Neurogastroenterol Motil. 2010 Nov;22(11):1191-200, e315. doi: 10.1111/j.1365-2982.2010.01554.x.

PMID:
20584260
17.

IGF-binding protein 1 and abdominal obesity in the development of type 2 diabetes in women.

Lewitt MS, Hilding A, Brismar K, Efendic S, Ostenson CG, Hall K.

Eur J Endocrinol. 2010 Aug;163(2):233-42. doi: 10.1530/EJE-10-0301. Epub 2010 May 27.

18.

Regulation of glucose uptake by endothelin-1 in human skeletal muscle in vivo and in vitro.

Shemyakin A, Salehzadeh F, Böhm F, Al-Khalili L, Gonon A, Wagner H, Efendic S, Krook A, Pernow J.

J Clin Endocrinol Metab. 2010 May;95(5):2359-66. doi: 10.1210/jc.2009-1506. Epub 2010 Mar 5.

PMID:
20207830
19.

SOX2 has gender-specific genetic effects on diabetic nephropathy in samples from patients with type 1 diabetes mellitus in the GoKinD study.

Gu HF, Alvarsson A, Efendic S, Brismar K.

Gend Med. 2009 Dec;6(4):555-64. doi: 10.1016/j.genm.2009.11.001.

PMID:
20114006
20.

AKAP 18 alpha and gamma have opposing effects on insulin release in INS-1E cells.

Josefsen K, Lee YC, Thams P, Efendic S, Nielsen JH.

FEBS Lett. 2010 Jan 4;584(1):81-5. doi: 10.1016/j.febslet.2009.10.086.

21.

β-Cell research - A decade of rapid growth.

Ahrén B, Accili D, Boitard C, Efendic S, Henquin JC, Seino S, Steiner DF, Cerasi E.

Diabetes Obes Metab. 2009 Nov;11 Suppl 4:iv-ix. doi: 10.1111/j.1463-1326.2009.01143.x. No abstract available.

PMID:
19817782
22.

Functional and genetic analysis in type 2 diabetes of liver X receptor alleles--a cohort study.

Dahlman I, Nilsson M, Gu HF, Lecoeur C, Efendic S, Ostenson CG, Brismar K, Gustafsson JA, Froguel P, Vaxillaire M, Dahlman-Wright K, Steffensen KR.

BMC Med Genet. 2009 Mar 17;10:27. doi: 10.1186/1471-2350-10-27.

23.

The incretin hormones GIP and GLP-1 in diabetic rats: effects on insulin secretion and small bowel motility.

Edholm T, Cejvan K, Abdel-Halim SM, Efendic S, Schmidt PT, Hellström PM.

Neurogastroenterol Motil. 2009 Mar;21(3):313-21. doi: 10.1111/j.1365-2982.2008.01229.x. Epub 2008 Dec 18.

PMID:
19126188
24.

Loci of TCF7L2, HHEX and IDE on chromosome 10q and the susceptibility of their genetic polymorphisms to type 2 diabetes.

Nordman S, Ostenson CG, Efendic S, Gu HF.

Exp Clin Endocrinol Diabetes. 2009 Apr;117(4):186-90. doi: 10.1055/s-0028-1100419. Epub 2008 Dec 3.

PMID:
19053027
25.

Apolipoprotein M promoter polymorphisms alter promoter activity and confer the susceptibility to the development of type 1 diabetes.

Wu X, Niu N, Brismar K, Zhu X, Wang X, Efendic S, Du T, Liu Y, Gu HF, Liu Y.

Clin Biochem. 2009 Jan;42(1-2):17-21. doi: 10.1016/j.clinbiochem.2008.10.008. Epub 2008 Oct 30.

PMID:
19007767
26.

Pancreatic beta-cell mass or beta-cell function? That is the question!

Henquin JC, Cerasi E, Efendic S, Steiner DF, Boitard C.

Diabetes Obes Metab. 2008 Nov;10 Suppl 4:1-4. doi: 10.1111/j.1463-1326.2008.00968.x. No abstract available.

PMID:
18834427
27.

Estrogen receptor alpha gene variants associate with type 2 diabetes and fasting plasma glucose.

Dahlman I, Vaxillaire M, Nilsson M, Lecoeur C, Gu HF, Cavalcanti-Proença C, Efendic S, Ostenson CG, Brismar K, Charpentier G, Gustafsson JA, Froguel P, Dahlman-Wright K, Steffensen KR.

Pharmacogenet Genomics. 2008 Nov;18(11):967-75. doi: 10.1097/FPC.0b013e32831101ef.

PMID:
18854778
28.

Lack of an association between GHR exon 3 polymorphism and diabetic nephropathy in the Genetics of Kidneys in Diabetes (GoKinD) population.

Gu HF, Efendic S, Brismar K.

Diabetologia. 2008 Dec;51(12):2333-4. doi: 10.1007/s00125-008-1145-2. Epub 2008 Sep 5. No abstract available.

PMID:
18820897
29.

Evaluation of genetic association and expression reduction of TRPC1 in the development of diabetic nephropathy.

Zhang D, Freedman BI, Flekac M, Santos E, Hicks PJ, Bowden DW, Efendic S, Brismar K, Gu HF.

Am J Nephrol. 2009;29(3):244-51. doi: 10.1159/000157627. Epub 2008 Sep 19.

30.

The estrogen receptor {alpha}-selective agonist propyl pyrazole triol improves glucose tolerance in ob/ob mice; potential molecular mechanisms.

Lundholm L, Bryzgalova G, Gao H, Portwood N, Fält S, Berndt KD, Dicker A, Galuska D, Zierath JR, Gustafsson JA, Efendic S, Dahlman-Wright K, Khan A.

J Endocrinol. 2008 Nov;199(2):275-86. doi: 10.1677/JOE-08-0192. Epub 2008 Aug 29.

PMID:
18757549
31.

Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice.

Bryzgalova G, Lundholm L, Portwood N, Gustafsson JA, Khan A, Efendic S, Dahlman-Wright K.

Am J Physiol Endocrinol Metab. 2008 Oct;295(4):E904-12. doi: 10.1152/ajpendo.90248.2008. Epub 2008 Aug 12.

32.

Impaired glucose-stimulated insulin secretion in the GK rat is associated with abnormalities in islet nitric oxide production.

Mosén H, Ostenson CG, Lundquist I, Alm P, Henningsson R, Jimenez-Feltström J, Guenifi A, Efendic S, Salehi A.

Regul Pept. 2008 Nov 29;151(1-3):139-46. doi: 10.1016/j.regpep.2008.07.002. Epub 2008 Jul 11.

PMID:
18662725
33.

A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study.

Zhang D, Ma J, Brismar K, Efendic S, Gu HF.

J Diabetes Complications. 2009 Jul-Aug;23(4):265-72. doi: 10.1016/j.jdiacomp.2008.05.004. Epub 2008 Jul 3.

PMID:
18599322
34.

[Reply on new drugs against type 2 diabetes: important to gain experience and knowledge].

Sjöholm A, Agardh CD, Brismar K, Efendic S, Eliasson B, Eriksson JW, Frid A, Groop L, Holmgren J, Ridderstråle M, Smith U.

Lakartidningen. 2008 Apr 23-May 6;105(17-18):1310, 1312. Swedish. No abstract available.

PMID:
18561535
35.

Psychological distress and risk of pre-diabetes and Type 2 diabetes in a prospective study of Swedish middle-aged men and women.

Eriksson AK, Ekbom A, Granath F, Hilding A, Efendic S, Ostenson CG.

Diabet Med. 2008 Jul;25(7):834-42. doi: 10.1111/j.1464-5491.2008.02463.x.

PMID:
18513304
36.
37.

Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men.

Lewitt MS, Hilding A, Ostenson CG, Efendic S, Brismar K, Hall K.

Diabetologia. 2008 Jul;51(7):1135-45. doi: 10.1007/s00125-008-1016-x. Epub 2008 May 22.

PMID:
18496669
38.

Excessive islet NO generation in type 2 diabetic GK rats coincides with abnormal hormone secretion and is counteracted by GLP-1.

Salehi A, Meidute Abaraviciene S, Jimenez-Feltstrom J, Ostenson CG, Efendic S, Lundquist I.

PLoS One. 2008 May 14;3(5):e2165. doi: 10.1371/journal.pone.0002165. Erratum in: PLoS ONE. 2008;3(6). doi: 10.1371/annotation/5efa5d3b-2733-4629-9592-f41e0814ca0b. PLoS ONE. 2008;3(6). doi: 10.1371/annotation/a72da6a5-a71a-4cc9-ae2b-2b95c0ec89b0. PLoS ONE. 2008;3(6). doi: 10.1371/annotation/bea154a4-93b3-4f1a-9948-acbaae12d256.

39.

Proteins in the insulin-secreting cell line MIN6 bind the imidazoline compound BL11282.

Shafqat J, Ishrat M, Jägerbrink T, Sillard R, Mäeorg U, Efendic S, Berggren PO, Zaitsev SV, Jörnvall H.

FEBS Lett. 2008 May 14;582(11):1613-7. doi: 10.1016/j.febslet.2008.04.007. Epub 2008 Apr 15.

40.

Contribution of gluconeogenesis and glycogenolysis to hepatic glucose production in acromegaly before and after pituitary microsurgery.

Höybye C, Chandramouli V, Efendic S, Hulting AL, Landau BR, Schumann WC, Wajngot A.

Horm Metab Res. 2008 Jul;40(7):498-501. doi: 10.1055/s-2008-1065322. Epub 2008 Mar 31.

PMID:
18393170
41.

GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome.

Hellström PM, Näslund E, Edholm T, Schmidt PT, Kristensen J, Theodorsson E, Holst JJ, Efendic S.

Neurogastroenterol Motil. 2008 Jun;20(6):649-59. doi: 10.1111/j.1365-2982.2007.01079.x. Epub 2008 Feb 19.

PMID:
18298441
42.

Insulin glargine improves glycaemic control after coronary surgery in patients with diabetes or pre-diabetes.

Hagelberg A, Ivert T, Efendić S, Ohrvik J, Anderson RE.

Scand Cardiovasc J. 2008 Feb;42(1):71-6. doi: 10.1080/14017430701721756.

PMID:
18273733
43.

Postprandial paradoxical IGFBP-1 response in obese patients with Type 2 diabetes.

Lehtihet M, Efendic S, Brismar K.

Clin Sci (Lond). 2008 Sep;115(5):167-74. doi: 10.1042/CS20070372.

PMID:
18208402
44.

Pathophysiology and treatment of patients with type 2 diabetes exhibiting failure to oral drugs.

Efendic S, Alvarsson M, Brismar K, Wagner H.

Acta Physiol (Oxf). 2008 Jan;192(1):117-25. doi: 10.1111/j.1748-1716.2007.01789.x. Review.

PMID:
18171434
45.

Distribution of neuropeptide Y Leu7Pro polymorphism in patients with type 1 diabetes and diabetic nephropathy among Swedish and American populations.

Ma J, Nordman S, Möllsten A, Falhammar H, Brismar K, Dahlquist G, Efendic S, Gu HF.

Eur J Endocrinol. 2007 Nov;157(5):641-5.

PMID:
17984244
46.

Arachidonic acid signaling is involved in the mechanism of imidazoline-induced KATP channel-independent stimulation of insulin secretion.

Sharoyko VV, Zaitseva II, Leibiger B, Efendić S, Berggren PO, Zaitsev SV.

Cell Mol Life Sci. 2007 Nov;64(22):2985-93.

PMID:
17922229
47.

Islet gene expression and function in type 2 diabetes; studies in the Goto-Kakizaki rat and humans.

Ostenson CG, Efendic S.

Diabetes Obes Metab. 2007 Nov;9 Suppl 2:180-6. Review.

PMID:
17919192
48.

Of mighty mice and diabetic men: animal models of islet dysfunction.

Efendic S, Boitard C, Ferrannini E, Henquin JC, Steiner DF, Cerasi E.

Diabetes Obes Metab. 2007 Nov;9 Suppl 2:1-4. No abstract available.

PMID:
17919172
49.

Genetic variation of the adenylyl cyclase 3 (AC3) locus and its influence on type 2 diabetes and obesity susceptibility in Swedish men.

Nordman S, Abulaiti A, Hilding A, Långberg EC, Humphreys K, Ostenson CG, Efendic S, Gu HF.

Int J Obes (Lond). 2008 Mar;32(3):407-12. Epub 2007 Sep 25.

PMID:
17895882
50.

Genetic variation in receptor protein tyrosine phosphatase sigma is associated with type 2 diabetes in Swedish Caucasians.

Långberg EC, Gu HF, Nordman S, Efendic S, Ostenson CG.

Eur J Endocrinol. 2007 Oct;157(4):459-64.

PMID:
17893260

Supplemental Content

Loading ...
Support Center